Yes gettting reimbursement/funding for new tests in the institutional settings and other agencies has many hurdles. Getting regulatory approval is only the first step. A product will not "take off" until the specialised commitees which usually are stacked with conservative clinicians as well as the "bean counters" finally are convinced of the cost / benefits. Only rarely do products appear that get priority funding. It all takes time and a lot of evidence.
- Forums
- ASX - By Stock
- it aint so easy
Yes gettting reimbursement/funding for new tests in the...
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CST (ASX) to my watchlist
The Watchlist
NXD
NEXTED GROUP LIMITED
Nick Poll, Managing Director
Nick Poll
Managing Director
SPONSORED BY The Market Online